首页> 美国卫生研究院文献>other >Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery
【2h】

Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery

机译:最大化支持的双层现象:脂质体仅包含聚乙二醇化磷脂以增强全身和淋巴输送。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditional liposomes degrade into lower-order micelles when PEGylated to even minor degrees (6–7 mol %) and therefore can offer only limited steric exclusion against opsonization during in vivo delivery. In this work, we present for the first time a liposome coated exclusively by PEGylated phospholipids, utilizing lipid-coated calcium phosphate (CaP) cores of diverse sizes (10–15 nm, 30–40 nm) as well as varying polyethylene glycol (PEG) chain lengths (350–5000 Da). Such fully-PEGylated liposome calcium phosphate (LCP) particles exhibit a PEG chain length-dependent circulation longevity and robust immune evasion, while facilitating both strong accumulation within solid tumors upon intravenous injection and a more rapid and extensive lymphatic drainage upon subcutaneous administration. Further, these fully-PEGylated liposomes remain amenable to active targeting strategies which facilitate improved degrees of focused distribution and nanoparticle uptake, represent a lipid packing density commensurate with the formation of a lipid bilayer, and avoid use of scale-limited physical resuspension methods. We expect such improved delivery properties to translate into improved therapeutic safety and efficacy for a variety of systemic and lymphatic diseases.
机译:传统脂质体在聚乙二醇化程度很小(6-7 mol%)时降解为低级胶束,因此在体内递送过程中只能提供有限的空间排除调理作用。在这项工作中,我们首次展示了仅由聚乙二醇化磷脂包被的脂质体,它利用了各种大小(10–15 nm,30–40 nm)的脂质包裹的磷酸钙(CaP)核以及各种聚乙二醇(PEG) )链长(350–5000 Da)。此类完全聚乙二醇化的脂质体磷酸钙(LCP)颗粒具有PEG链长度依赖性的循环寿命和强大的免疫逃逸性,同时促进了静脉注射后实体瘤内的强积累和皮下给药后更快,更广泛的淋巴引流。此外,这些完全聚乙二醇化的脂质体仍然适合于主动靶向策略,该策略有助于改善集中分布和纳米颗粒摄取的程度,代表与脂质双层形成相对应的脂质堆积密度,并且避免使用规模受限的物理重悬浮方法。我们期望这种改善的递送性质转化成对多种全身和淋巴疾病的改善的治疗安全性和功效。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号